Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 1
2008 1
2017 1
2018 2
2019 2
2021 5
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N, Konnai S, Hosoya K, Kim S, Kinoshita R, Deguchi T, Owaki R, Tachibana Y, Yokokawa M, Takeuchi H, Kagawa Y, Takagi S, Ohta H, Kato Y, Yamamoto S, Yamamoto K, Suzuki Y, Okagawa T, Murata S, Ohashi K. Maekawa N, et al. Among authors: deguchi t. PLoS One. 2023 Oct 4;18(10):e0291727. doi: 10.1371/journal.pone.0291727. eCollection 2023. PLoS One. 2023. PMID: 37792729 Free PMC article.
Mandibular vascular hamartoma in a cat.
Takagi S, Kagawa Y, Hanazono K, Murakami S, Deguchi T, Izumi Y, Hosoya K, Kim S, Okumura M. Takagi S, et al. Among authors: deguchi t. J Vet Med Sci. 2018 Sep 26;80(9):1456-1458. doi: 10.1292/jvms.18-0148. Epub 2018 Jul 13. J Vet Med Sci. 2018. PMID: 30012929 Free PMC article.
Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.
Deguchi T, Maekawa N, Konnai S, Owaki R, Hosoya K, Morishita K, Nakamura M, Okagawa T, Takeuchi H, Kim S, Kinoshita R, Tachibana Y, Yokokawa M, Takagi S, Kato Y, Suzuki Y, Murata S, Ohashi K. Deguchi T, et al. Cancers (Basel). 2023 Jun 1;15(11):3013. doi: 10.3390/cancers15113013. Cancers (Basel). 2023. PMID: 37296981 Free PMC article.
Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.
Maekawa N, Konnai S, Asano Y, Sajiki Y, Deguchi T, Okagawa T, Watari K, Takeuchi H, Takagi S, Hosoya K, Kim S, Ohta H, Kato Y, Suzuki Y, Murata S, Ohashi K. Maekawa N, et al. Among authors: deguchi t. Sci Rep. 2022 Jun 3;12(1):9265. doi: 10.1038/s41598-022-13484-8. Sci Rep. 2022. PMID: 35665759 Free PMC article.
Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumors.
Maekawa N, Konnai S, Asano Y, Otsuka T, Aoki E, Takeuchi H, Kato Y, Kaneko MK, Yamada S, Kagawa Y, Nishimura M, Takagi S, Deguchi T, Ohta H, Nakagawa T, Suzuki Y, Okagawa T, Murata S, Ohashi K. Maekawa N, et al. Among authors: deguchi t. PLoS One. 2023 Jan 26;18(1):e0281143. doi: 10.1371/journal.pone.0281143. eCollection 2023. PLoS One. 2023. PMID: 36701405 Free PMC article.
PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma.
Maekawa N, Konnai S, Nishimura M, Kagawa Y, Takagi S, Hosoya K, Ohta H, Kim S, Okagawa T, Izumi Y, Deguchi T, Kato Y, Yamamoto S, Yamamoto K, Toda M, Nakajima C, Suzuki Y, Murata S, Ohashi K. Maekawa N, et al. Among authors: deguchi t. NPJ Precis Oncol. 2021 Feb 12;5(1):10. doi: 10.1038/s41698-021-00147-6. NPJ Precis Oncol. 2021. PMID: 33580183 Free PMC article.
23 results